Literature DB >> 10366558

Specific and nonspecific immune stimulation of MHC-II-deficient mice results in chronic HSV-1 infection of the trigeminal ganglia following ocular challenge.

H Ghiasi1, G C Perng, F M Hofman, S Cai, A B Nesburn, S L Wechsler, G C Pemg.   

Abstract

Ocular herpes simplex virus type 1 (HSV-1) infection of MHC-II-deficient mice (AO/Obeta mice) or their parental C57BL/6J wild-type mice resulted in the establishment of typical HSV-1 latent infections in the trigeminal ganglia (TG) of the surviving mice by day 28 postinfection. Latency was characterized by the complete absence of infectious virus in TG extracts, the ability to recover latent virus only following prolonged tissue culture cultivation of explanted TG, and the presence of HSV-1 DNA in TG extracts. When mice were vaccinated prior to ocular HSV-1 challenge, latency appeared unaltered in the C57BL/6J wild-type mice. However, in AO/Obeta mice, clearance of virus from the TG appeared to be seriously impaired, resulting in a chronic productive infection, rather than a latent infection. Infectious virus was readily detected in TG extracts of vaccinated AO/Obeta mice until at least 63 days postinfection. Glycoprotein B mRNA was also readily detected, confirming continued viral transcription. These chronic infections occurred regardless of whether the AO/Obeta mice were vaccinated with HSV-1-specific antigens (i.e., live HSV-1 strain KOS, recombinantly expressed HSV-1 glycoprotein D plus Freund's adjuvant, or a mixture of seven recombinantly expressed HSV-1 glycoproteins plus adjuvant) or non-HSV-1-specific antigens (i.e., tissue culture medium plus 5% fetal bovine serum, the expression vector plus adjuvant, or adjuvant alone). Passive transfer of HSV-1 neutralizing antibody to vaccinated AO/Obeta mice between days 0 and 28 post-ocular challenge did not clear infectious virus from the TG. Passive transfer of anti-HSV-1 antibody or purified naive mouse serum to unvaccinated AO/Obeta mice on days 3 or 6 post-HSV-1 ocular challenge also resulted in chronic, rather than latent, infection of the TG. Passive transfer of naive sera from B-cell-deficient mice or injection of keyhole limpet hemocyanin or purified IgG, but not PBS or dextran, 3 days after HSV-1 challenge also resulted in chronic infection of the TG. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10366558     DOI: 10.1006/viro.1999.9710

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  12 in total

1.  Subclinical Herpes Simplex Virus Type 1 Infections Provide Site-Specific Resistance to an Unrelated Pathogen.

Authors:  Alexander M Rowe; Hongming Yun; Benjamin R Treat; Paul R Kinchington; Robert L Hendricks
Journal:  J Immunol       Date:  2017-01-06       Impact factor: 5.422

2.  An M2 Rather than a TH2 Response Contributes to Better Protection against Latency Reactivation following Ocular Infection of Naive Mice with a Recombinant Herpes Simplex Virus 1 Expressing Murine Interleukin-4.

Authors:  Dhong Hyun Lee; Homayon Ghiasi
Journal:  J Virol       Date:  2018-04-27       Impact factor: 5.103

3.  Recombinant herpes simplex virus type 1 (HSV-1) codelivering interleukin-12p35 as a molecular adjuvant enhances the protective immune response against ocular HSV-1 challenge.

Authors:  Yanira Osorio; Homayon Ghiasi
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

4.  Recombinant herpes simplex virus type 1 expressing murine interleukin-4 is less virulent than wild-type virus in mice.

Authors:  H Ghiasi; Y Osorio; G C Perng; A B Nesburn; S L Wechsler
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

5.  A recombinant herpes simplex virus type 1 expressing two additional copies of gK is more pathogenic than wild-type virus in two different strains of mice.

Authors:  Kevin R Mott; Guey-Chuen Perng; Yanira Osorio; Konstantin G Kousoulas; Homayon Ghiasi
Journal:  J Virol       Date:  2007-09-26       Impact factor: 5.103

6.  Effect of undernourishment on Herpes Simplex Virus Type 1 ocular infection in the Wistar rat model.

Authors:  Fabian Benencia; Gisela Gamba; Ruben Benedetti; Maria C Courreges; Hernan Cavalieri; Ernesto J Massouh
Journal:  Int J Exp Pathol       Date:  2002-04       Impact factor: 1.925

7.  Overexpression of interleukin-2 by a recombinant herpes simplex virus type 1 attenuates pathogenicity and enhances antiviral immunity.

Authors:  Homayon Ghiasi; Yanira Osorio; Guey-Chuen Perng; Anthony B Nesburn; Steven L Wechsler
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

8.  Reply to "Herpes Simplex Virus 1, Macrophages, and the Cornea".

Authors:  Dhong Hyun Lee; Homayon Ghiasi
Journal:  J Virol       Date:  2017-10-13       Impact factor: 5.103

9.  Lymphoid-related CD11c+ CD8alpha+ dendritic cells are involved in enhancing herpes simplex virus type 1 latency.

Authors:  Kevin R Mott; David Underhill; Steven L Wechsler; Homayon Ghiasi
Journal:  J Virol       Date:  2008-07-30       Impact factor: 5.103

10.  Interrelationship of Primary Virus Replication, Level of Latency, and Time to Reactivation in the Trigeminal Ganglia of Latently Infected Mice.

Authors:  Harry H Matundan; Kevin R Mott; Sariah J Allen; Shaohui Wang; Catherine J Bresee; Yasamin N Ghiasi; Terrence Town; Steven L Wechsler; Homayon Ghiasi
Journal:  J Virol       Date:  2016-09-29       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.